Independent validation of Parkinson’s disease Sleep Scale 2nd version (PDSS-2)

[1]  K. Hirata,et al.  Evaluation of cutoff scores for the Parkinson's disease sleep scale‐2 , 2015, Acta neurologica Scandinavica.

[2]  J. Kállai,et al.  Screening Mild and Major Neurocognitive Disorders in Parkinson's Disease , 2015, Behavioural neurology.

[3]  G. Stebbins,et al.  Assessing the non‐motor symptoms of Parkinson's disease: MDS‐UPDRS and NMS Scale , 2015, European journal of neurology.

[4]  J. Janszky,et al.  [The impact of levodopa-carbidopa intestinal gel on health-related quality of life in Parkinson's disease]. , 2014, Ideggyogyaszati szemle.

[5]  J. Weiss,et al.  Nocturia causes vary with each decade , 2014, Current opinion in urology.

[6]  P. Martínez-Martín,et al.  Rating scales and questionnaires for assessment of sleep disorders in Parkinson’s disease: what they inform about? , 2014, Journal of Neural Transmission.

[7]  D. Santos-García,et al.  Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease , 2013, Journal of the Neurological Sciences.

[8]  F. Marrosu,et al.  Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson's disease , 2012, Journal of the Neurological Sciences.

[9]  A. Pisani,et al.  The progression of non-motor symptoms in Parkinson’s disease and their contribution to motor disability and quality of life , 2012, Journal of Neurology.

[10]  J. Kállai,et al.  Sensitivity and specificity of Addenbrooke's Cognitive Examination, Mattis Dementia Rating Scale, Frontal Assessment Battery and Mini Mental State Examination for diagnosing dementia in Parkinson's disease. , 2012, Parkinsonism & related disorders.

[11]  D. Aarsland,et al.  Gender-related differences in the burden of non-motor symptoms in Parkinson’s disease , 2012, Journal of Neurology.

[12]  Kallol Ray Chaudhuri,et al.  Parkinson's disease sleep scale—validation of the revised version PDSS‐2 , 2011, Movement disorders : official journal of the Movement Disorder Society.

[13]  K. Chaudhuri,et al.  The impact of non‐motor symptoms on health‐related quality of life of patients with Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.

[14]  W. Poewe,et al.  Scales to assess sleep impairment in Parkinson's disease: Critique and recommendations , 2010, Movement disorders : official journal of the Movement Disorder Society.

[15]  T. Anderson,et al.  Rotigotine Effects on Early Morning Motor Function and Sleep in Parkinson's Disease: A Double-Blind, Randomized, pLacebo-Controlled Study (RECOVER) , 2010, Movement disorders : official journal of the Movement Disorder Society.

[16]  C. Clarke,et al.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[17]  N. Kovács,et al.  The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: A randomized, double‐blind, placebo‐controlled study , 2010, Movement disorders : official journal of the Movement Disorder Society.

[18]  J. Jankovic,et al.  Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results , 2008, Movement disorders : official journal of the Movement Disorder Society.

[19]  A. Thompson,et al.  Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome. , 2004, Health technology assessment.

[20]  C Trenkwalder,et al.  The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease , 2002, Journal of neurology, neurosurgery, and psychiatry.

[21]  Kathleenl N. Lohr,et al.  Assessing health status and quality-of-life instruments: Attributes and review criteria , 2002, Quality of Life Research.

[22]  A Thompson,et al.  The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. , 2001, Brain : a journal of neurology.

[23]  C. McHorney,et al.  Individual-patient monitoring in clinical practice: are available health status surveys adequate? , 1995, Quality of Life Research.

[24]  R. Hays,et al.  Psychometric considerations in evaluating health-related quality of life measures , 1993, Quality of Life Research.

[25]  T. Dóczi,et al.  Bilateral Subthalamic Stimulation can Improve Sleep Quality in Parkinson's Disease. , 2015, Journal of Parkinson's disease.

[26]  P. Klivényi,et al.  [VALIDATION OF THE HUNGARIAN MDS-UPDRS: WHY DO WE NEED A NEW PARKINSON SCALE?]. , 2014, Ideggyogyaszati szemle.

[27]  B. Faludi,et al.  Test-retest validity of Parkinson's disease sleep scale 2nd version (PDSS-2). , 2014, Journal of Parkinson's disease.

[28]  K. Janacsek,et al.  [Hungarian version of the Montreal Cognitive Assessment (MoCA) for screening mild cognitive impairment]. , 2013, Psychiatria Hungarica : A Magyar Pszichiatriai Tarsasag tudomanyos folyoirata.